The Effects of a Single Session of Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients

December 14, 2023 updated by: Matthew Wyon, University of Wolverhampton

The Effects of a Single Session of Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients: A Methodological Approach.

The aim of the present study is to examine the acute effects of a specially designed musicokinetic (MSK) program for patients with Parkinson's disease (PD) on a) anxiety levels b) select kinematic and kinetic parameters, and c) frontal cortex hemodynamic responses, during gait initiation and steady-state walking.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

This is a blind cross over randomized control trial (RCT) in which 13 volunteers with PD will attend a 45 min MSK program under the following conditions: a) synchronous learning format, b) asynchronous remote video- based, and c) control conditions. Changes in gait biomechanics and frontal cortex hemodynamic responses will be examined using a 10-camera 3D motion analysis (Vicon T-series, Oxford, UK), and a functional near-infrared spectroscopy (f-NIRS - Portalite, Artinis, NL) system, respectively, while anxiety levels will be evaluated using the Hamilton Anxiety Rating Scale.

Study Type

Interventional

Enrollment (Estimated)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • West Midlands
      • Walsall, West Midlands, United Kingdom, WS1 3BD
        • University of Wolverhampton

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hoehn and Yahr (H&Y) Parkinson disease scale I-III
  • No restriction on disease duration,
  • No restriction on type of drug therapy
  • Stable antiparkinsonian medication of at least 6 months
  • Data collections will be "on" medication
  • No participation to any other exercise program for at least 2 months
  • 100% attendance of the session.

Exclusion Criteria:

  • Dementia
  • Deep brain stimulation,
  • Cancer,
  • Cardiovascular diseases
  • Poor visual capability
  • Poor or auditory capability
  • Musculoskeletal problems
  • No stable antiparkinsonian therapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: synchronous learning format
Volunteers will be asked to attend synchronous learning format MSK Training. The exercise protocol has a duration of 45 minutes of rhythmic training and includes sections of warming-up, stretching, breathing, movement combinations, a dance sequence and recovery. Each exercise is accompanied with music that provides a clear and predictable rhythm. More specifically, the beat or rhythm of the music is used as a guide for the timing and duration of specific movements, allowing people with PD to coordinate their movements with the music. Simple values are going to be introduced such as whole notes, half notes and quarter notes; clapping and tapping, breathing and sounds. Class will be accompanied by recorded classical piano music, to meet the needs of synchronous learning format and asynchronous remote video-based format. The intensity of the class is moderate approximately 3 MET. The instructor is an experienced dance teacher in musicokinetic education.
The intervention protocols are either a) synchronous learning format, b) asynchronous remote video- based, and c) control.
Experimental: Asynchronous remote video-based format

Volunteers will be asked to attend asynchronous remote video-based format MSK Training.

The exercise protocol is the same as the synchronous format but delivered via a video-based format

The intervention protocols are either a) synchronous learning format, b) asynchronous remote video- based, and c) control.
No Intervention: Control
Volunteers will not be asked to sit quietly for a 45-minute period

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety
Time Frame: 1-2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Hamilton Anxiety rating scale. Scores of 17 or less indicates mild anxiety severity, 18 to 24 indicates mild to moderate anxiety severity, and 25 to 30 indicates a moderate to severe anxiety severity.
1-2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Dorsolateral pre-frontal cortex (DLPFC) blood markers during gait
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms

A portable fNIRS system (Portalite, Artinis Medical Solutions, Netherlands) will be applied to monitor concentration changes (mM), of O2Hb, HHb and total hemoglobin (tHb) and the difference between O2Hb and HHb [Hbdiff = O2Hb -HHb] of the dorsal lateral prefrontal cortex (DLPFC). To correct for scattering of photons in the tissue, a differential path-length factor (DPF) of 4.0 will be used, for the calculation of absolute concentration changes at a sample frequency of 10Hz. The NIRS probe will be placed in the Brodmann 46 region on the right DLPFC, which has been proposed to be more involved in regulating muscle fatigue and activation. Subsequently, the NIRS probe will be fixed with adhesive tape and a dark elastic bandage around the head to avoid external light and artifacts.

The O2Hb, HHb and tHb will be used as an indicator of DLPFC total activity, while the Hbdiff (i.e., oxygen supply vs demand) will be used as a marker of oxygenation in the DLPFC.

2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Gait initiation - balance
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms

Using two force plates in line the participant stands on the first, adapting a quite bipedal stance and after a verbal command, starts ambulating forwarding one leg and stepping on the second plate.

GRFs are calculated from both force plates, to evaluate the balance ability single leg stance (Fy+Fx)

2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Gait initiation - acceleration
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms

Using two force plates in line the participant stands on the first, adapting a quite bipedal stance and after a verbal command, starts ambulating forwarding one leg and stepping on the second plate.

GRFs are calculated from both force plates, to evaluate foot clear force (FZ) respectively (leg .1)

2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Walking kinematic parameters - stride length
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Ground reaction force (GRF) data captured at 1000 Hz for the right and left leg by the force platforms will be synchronized with the kinematic data obtained by the Vicon motion analysis system at 1000 Hz. Kinematic data will focus on stride length and time and shoulder-pelvis association.
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Walking kinematic parameters - shoulder-pelvis association
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Kinematic data obtained by the Vicon motion analysis system at 1000 Hz will focus on shoulder-pelvis association.
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Walking kinematic parameters - gait velocity
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Kinematic data obtained by the Vicon motion analysis system at 1000 Hz and will focus on gait velocity.
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Walking kinetic parameters - medio-lateral ground reaction forces
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
GRFs are calculated from both force plates, to evaluate the medio-lateral movement during the stance phase of walking (Fy+Fx)
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
Walking kinetic parameters- foot strike
Time Frame: 2 hours before the intervention arms and within 2 hours after the completion of the intervention arms
GRFs are calculated from both force plates, to evaluate the strike forces during landing (Fz)
2 hours before the intervention arms and within 2 hours after the completion of the intervention arms

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

May 28, 2023

First Submitted That Met QC Criteria

July 31, 2023

First Posted (Actual)

August 3, 2023

Study Record Updates

Last Update Posted (Actual)

December 15, 2023

Last Update Submitted That Met QC Criteria

December 14, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Musicokinetic Training

Subscribe